The emergency approval, ahead of the United States and the European Union, clears the way for Britain to begin mass inoculations. “Help is on its way,” one official said.
Tag: Pfizer Inc
How the Out-of-Control Pandemic Is Speeding the Testing of Vaccines
The surge in coronavirus cases worldwide is helping researchers measure more quickly how well their vaccines protect against Covid-19.
Early Data Show Moderna’s Coronavirus Vaccine Is 94.5% Effective
Moderna is the second company to report preliminary results from a large trial testing a vaccine. But there are still months to go before it will be widely available to the public.
How to Ship a Vaccine at –80°C, and Other Obstacles in the Covid Fight
Developing an effective vaccine is the first step. Then comes the question of how to deliver hundreds of millions of doses that may need to be kept at arctic temperatures.
Coronavirus Crisis Has Made Brazil an Ideal Vaccine Laboratory
Widespread contagion, a deep bench of scientists and a robust vaccine-making infrastructure have made Brazil an important player in the quest to find a vaccine.
Moderna and Pfizer Begin Late-Stage Coronavirus Vaccine Trials
The studies each aim to enroll 30,000 people and determine whether the vaccines are safe and effective.
Oxford Covid Vaccine Among Those Developers Say Have Promising Initial Results
Early trials showed a good immune response in vaccinated subjects, but one researcher sounded a note of caution: “There is still a long way to go.”